TDOC Teladoc Health Inc.

Teladoc Appoints Former CEO of Allina Health Ken Paulus to Board of Directors

Teladoc, Inc. (NYSE:TDOC), the undisputed leader in telehealth, providing access to care for millions, today announced that it has appointed Kenneth H. Paulus, 57, to its board of directors. Mr. Paulus will serve on the board's Nominating & Corporate Governance committee and its Quality & Safety committee.

"Ken is widely recognized as an outstanding leader in the provider market," said Jason Gorevic, president and CEO of Teladoc. "As Ken joins Teladoc on our mission to transform access to care, we look forward to his strategic insights that will enable us to further advance our footprint in hospitals and health systems across the U.S."

"Having already achieved significant milestones in telehealth, Teladoc has an attractive value proposition and will clearly continue to positively shape the healthcare landscape," said Paulus. “I’m proud to join Teladoc at this important time, and to support the company as it drives telehealth to be mainstream.”

As former president and CEO of Allina Health from 2009 to 2014, Paulus led one of the nation's largest not-for-profit integrated delivery systems consisting of nearly 1,500 employed physicians, 13 acute care hospitals, a freestanding emergency department and more than 100 ambulatory care clinics.

Before joining Allina, Paulus was the CEO of Atrius Health System, one of the largest integrated physician organizations in New England and a teaching and research affiliate of Harvard Medical School. He previously served as the Chief Operating Officer of Partners Community HealthCare – the integrated medical network representing Massachusetts General Hospital and Brigham and Women’s Hospital.

Paulus is currently an executive advisor at Water Street Healthcare Partners, a private investment firm. He received a Bachelor of Arts in biology at Augustana College and a Masters of Healthcare Administration and Management from the University of Minnesota.

About Teladoc

Teladoc, Inc. (NYSE:TDOC) is the nation’s leading provider of telehealth services and a pioneering force in bringing the virtual care visit into the mainstream of today’s health care ecosystem. Serving some 7,500 clients — including health plans, health systems, employers and other organizations — more than 17.5 million members can use phone, mobile devices and secure online video to connect within minutes to Teladoc’s network of more than 3,100 board-certified, state-licensed physicians and behavioral health specialists, 24/7. With national coverage, a robust, scalable platform and a Lewisville, TX-based member services center staffed by 400 employees, Teladoc offers the industry’s most comprehensive and complete telehealth solution including primary care, behavioral health care, dermatology, tobacco cessation and more. For additional information, please visit www.teladoc.com.

EN
02/03/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Teladoc Health Inc.

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and replay of the presentation will be available at .  About Teladoc Health Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating car...

 PRESS RELEASE

Teladoc Health to Participate in Upcoming Investor Conference

Teladoc Health to Participate in Upcoming Investor Conference NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) --  (NYSE: TDOC), the global leader in virtual care, today announced that Chuck Divita, chief executive officer, will participate in the 37th Annual Piper Sandler Healthcare Conference in New York on Tuesday, December 2, 2025, at 12:30 p.m. ET. A live audio webcast and replay of the presentation will be available at . About Teladoc HealthTeladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, pla...

Teladoc Health Inc: 1 director

A director at Teladoc Health Inc bought 10,000 shares at 6.940USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

 PRESS RELEASE

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303...

Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective November 1, 2025, in connection with commencing employment as Chief Technology Officer, Dave Ross was granted an award of restricted stock units covering 86,906 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”), and an award of performance stock units covering a target of 86,906 shares of C...

 PRESS RELEASE

Teladoc Health Reports Third Quarter 2025 Results

Teladoc Health Reports Third Quarter 2025 Results NEW YORK, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2025 (“Third Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended September 30, 2024 (“Third Quarter 2024”). Highlights Third Quarter 2025 revenue of $626.4 million, down 2% year-over-yearThird Quarter 2025 net loss of $49.5 million, or $0.28 per shareThird Quarter 2025 adjusted EBITDA of $69.9 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch